These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 36002115)

  • 21. Alma Dal Co (1989-2022).
    van Vliet S; Ackermann M
    Nat Ecol Evol; 2023 Mar; 7(3):310-311. PubMed ID: 36653434
    [No Abstract]   [Full Text] [Related]  

  • 22. Antimicrobial Treatment of
    Tuon FF; Suss PH; Telles JP; Dantas LR; Borges NH; Ribeiro VST
    Antibiotics (Basel); 2023 Jan; 12(1):. PubMed ID: 36671287
    [No Abstract]   [Full Text] [Related]  

  • 23. The MIC distribution of dalbavancin differs between different coagulase-negative staphylococci.
    Svensson S; Hagstedt P; Söderquist B
    JAC Antimicrob Resist; 2024 Apr; 6(2):dlae063. PubMed ID: 38601789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro Efficacy of Dalbavancin as a Long-Acting Anti-Biofilm Agent Loaded in Bone Cement.
    Sánchez-Somolinos M; Díaz-Navarro M; Benjumea A; Matas J; Vaquero J; Muñoz P; Sanz-Ruíz P; Guembe M
    Antibiotics (Basel); 2023 Sep; 12(9):. PubMed ID: 37760741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective use of a two-dose regimen of dalbavancin to treat prosthetic joint infections and spinal hardware infections.
    Doub JB; Alkayali T; Amoroso A; Nandi S; Talwani R
    Eur J Orthop Surg Traumatol; 2023 Dec; 33(8):3655-3659. PubMed ID: 37270761
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Söderquist B; Henningsson T; Stegger M
    Microorganisms; 2023 Feb; 11(3):. PubMed ID: 36985124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
    El Haj C; Murillo O; Ribera A; Lloberas N; Gómez-Junyent J; Tubau F; Fontova P; Cabellos C; Ariza J
    Int J Antimicrob Agents; 2018 Jun; 51(6):854-861. PubMed ID: 29374577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections.
    Sivori F; Cavallo I; Kovacs D; Guembe M; Sperduti I; Truglio M; Pasqua M; Prignano G; Mastrofrancesco A; Toma L; Pimpinelli F; Morrone A; Ensoli F; Di Domenico EG
    Microbiol Spectr; 2022 Apr; 10(2):e0035122. PubMed ID: 35416701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm.
    Parra-Ruiz J; Vidaillac C; Rose WE; Rybak MJ
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4329-34. PubMed ID: 20696880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
    Barber KE; Smith JR; Ireland CE; Boles BR; Rose WE; Rybak MJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4497-503. PubMed ID: 25987623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Telavancin Alone and Combined with Ceftaroline or Rifampin against Methicillin-Resistant Staphylococcus aureus in an
    Jahanbakhsh S; Singh NB; Yim J; Rose WE; Rybak MJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy of dalbavancin alone and with rifampicin against in vitro biofilms in a pharmacodynamic model with methicillin-resistant Staphylococcus aureus.
    El Haj C; Benavent E; Sierra Y; Soldevila L; Rigo-Bonnin R; Torrejón B; Gomez-Junyent J; Rosselló I; Murillo O
    Int J Antimicrob Agents; 2022 Oct; 60(4):106664. PubMed ID: 36002115
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.